Background To maximize the likelihood of positive outcome in non-small-cell lung cancer
(NSCLC) survivors, potential benefits of treatment modalities have to be weighed against the …

Background and purpose A higher radiation dose to the heart is known to be associated with
increased mortality in non-small cell lung cancer (NSCLC) patients. It is however unknown …

Background Radiation-induced cardiotoxicity poses a significant challenge in lung cancer
management because of the close anatomical proximity of the heart to the lungs …

Background Radiotherapy may cause grade≥ 3 cardiac events, necessitating a better
understanding of risk factors. The potential predictive role of imaging biomarkers with …

Purpose Some recent studies have suggested a relationship between cardiac dose and
mortality in non-small cell lung cancer (NSCLC), but others have reported conflicting data …

Aims To assess the risk of cardiac toxicity following radical radiotherapy in advanced lung
cancer patients. Materials and methods Patients with a diagnosis of stage III non-small cell …

Background: Radiation-induced heart disease (RIHD), which affects the patients' prognosis
with both acute and late side effects, has been published extensively in the radiotherapy of …

Purpose The significance of radiotherapy (RT)–associated cardiac injury for stage III non–
small-cell lung cancer (NSCLC) is unclear, but higher heart doses were associated with …

Background: Radiotherapy-associated cardiac toxicity studies in patients with locally
advanced non–small cell lung cancer (NSCLC) have been limited by small sample size and …

Radiation-induced heart disease (RIHD) is a recent concern in patients with lung cancer
after being treated with radiotherapy. Most of information we have in the field of cardiac …